Privia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 13,647 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 13,647 shares of the stock in a transaction on Friday, December 12th. The shares were sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the transaction, the director owned 68,188 shares of the company’s stock, valued at approximately $1,705,381.88. This represents a 16.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Privia Health Group Price Performance

Shares of Privia Health Group stock traded down $0.53 during trading on Tuesday, hitting $23.81. 814,953 shares of the company’s stock traded hands, compared to its average volume of 833,471. The firm’s fifty day moving average price is $24.45 and its 200 day moving average price is $22.80. Privia Health Group, Inc. has a twelve month low of $18.77 and a twelve month high of $26.51. The company has a market cap of $2.93 billion, a PE ratio of 183.17, a PEG ratio of 4.30 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. As a group, equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on PRVA shares. Barclays raised their target price on Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Stephens reaffirmed an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a report on Thursday, December 4th. Finally, Truist Financial reiterated a “buy” rating and set a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a research report on Monday, November 10th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $30.42.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of PRVA. Russell Investments Group Ltd. grew its holdings in shares of Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares during the last quarter. CWM LLC raised its holdings in shares of Privia Health Group by 89.4% in the second quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after buying an additional 1,612 shares during the last quarter. Canada Pension Plan Investment Board lifted its position in Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after buying an additional 1,200 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Privia Health Group during the 2nd quarter worth about $113,000. Finally, Covestor Ltd grew its holdings in Privia Health Group by 39.8% during the 3rd quarter. Covestor Ltd now owns 5,824 shares of the company’s stock worth $145,000 after acquiring an additional 1,657 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.